RSS Feed Link

November

Venture Capital: Dead or Alive in the 21st Century?

Is venture capital still viable as a model for funding new bioscience research, products and businesses?

[More]
Posted by: Rita Baron-Faust
on November 15, 2013
Category:  Creation  Growth  Execution 
eMed's 6 to follow in entrepreneurship

See who made this week's 6 to follow in entrepreneurship

[More]
Posted by: Ryan Amin
on November 15, 2013
Category:  Creation  Growth  Execution  Ideation 
What are the red flags when looking for a co-founder?

Jason Greenberg of the Leonard N. Stern School of Business led a co-founder issues discussion with Stephen Cary, Elliot Cohen, Lesa Mitchell, Elizabeth Iorns and Jonathan Bloom at a Life Science Ventures Summit hosted by the Kauffman Foundation(0:12:15-0:21:05).

[More]
Posted by: Ryan Amin
on November 14, 2013
Category:  Creation 
Device design tips for diabetes and healthcare startups

The race for the first noninvasive glucose meter to hit the market is well underway and many more healthcare startups are entering the competitive diabetes treatment space. While trying to treat a large patient population, it's still necessary to focus on the details and patient needs. It's time to really drill down the market research and think about what kind of patients will use your medtech and how and how your company's value to patients and providers might change over time. Neurometrix (NURO) founder and CEO Shai Gozani had these two key pieces of advice for diabetes treatment startups:

[More]
Posted by: MedCityNews .com
on November 13, 2013
Category:  Ideation  Execution 
Why your innovation should complement rather than disrupt

Dr. Joshua Landy understands the importance of sharing medical experiences with other physicians. He wanted to take it a step further and make those experiences valuable to a greater range of healthcare professionals. Landy decided to launch Figure 1, hoping that it would change the way physicians worked day-to-day, and also make their daily work more accessible to their peers.

[More]
Posted by: Ryan Amin
on November 12, 2013
Category:  Creation  Ideation 
Medical devices should focus on transparency, austerity and wellness

The CEO of a startup credited his company's success in raising money to two factors. Human data about the dissolving stent and a tight budget. Kamal Ramzipoor of Amaranth Medical said those two accomplishments helped his company raise $20 million in a series B round.

[More]
Posted by: MedCityNews .com
on November 11, 2013
Category:  Creation  Execution 
eMed's 6 to follow in entrepreneurship

See who made eMed's 6 to follow this week

[More]
Posted by: Ryan Amin
on November 8, 2013
Category:  Creation  Execution  Growth  Ideation 
What is holding your therapeutics pitch back?

Douglas Crawford of QB3 moderated a therapeutics funding panel at a recent Life Science Ventures Summit hosted by the Kauffman Foundation. Crawford focused a majority of the discussion on pitch strategies with Allan May, Karl Handelsman and Jesus Soriano

[More]
Posted by: Ryan Amin
on November 7, 2013
Category:  Creation  Execution 
Finding better ways to negotiate biotech intellectual property

Healthcare entrepreneurs who have hit the intellectual property speed bump can relate to the appropriately named session, "Reducing Drag: New Approaches to IP Negotiation and Technology Licensing," at the Partnering for Cures conference earlier this week in New York City.

[More]
Posted by: Rita Baron-Faust
on November 6, 2013
Category:  Creation  Execution 
Think beyond great idea, understand hospital perspective

Selling new healthcare technologies to hospitals requires jumping over hurdles like "major capital constraints" and "interminable" sales cycle of hospitals, says Paul Levy.

[More]
Posted by: MedCityNews .com
on November 6, 2013
Category:  Creation